Register information Patent

DE file number : 60 2009 004 618.7 (Status: pending/in force, Query started: May 6, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2009 004 618.7
96EP file numberEAKZ09 78 6960.6
86WO file numberWAKZPCT/IB2009/053626
97EP publication numberEPN2334687
87WO publication numberWPN2010023594
54Designation/titleTIDIOXABICYCLO[3.2.1]OCTAN-2,3,4-TRIOLDERIVATE
51IPC main classICM
(ICMV)		 C07D 493/10 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07H 15/18 (2006.01), A61K 31/357 (2006.01), A61P 3/10 (2006.01)
22DE application dateDATAug 17, 2009
96EP application dateEATAug 17, 2009
86WO application dateWATAug 17, 2009
43Date of first publicationOTMar 4, 2010
Date of publication of grantPETJan 4, 2012
71/73Applicant/ownerINHPfizer Inc. (n.d.Ges.d.Staates Delaware), New York, NY, US
72InventorINMASCITTI, Vincent, Groton, Connecticut 06340, US; COLLMAN, Benjamin, Micah, Groton, Connecticut 06340, US
74RepresentativeVTRKraus & Lederer PartGmbB, 80539 München, DE
Address for service Kraus & Lederer PartGmbB, 80539 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
227212 P
Jul 21, 2009
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
92470 P
Aug 28, 2008
Due dateFT
FG		Aug 31, 2025
Annual fee for the 17th year Patent fees
Patent division in charge 44
21File number of protection certificateZAKZ12 2018 000 070.1
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002334687
Searchable text: EP000002334687
Original document: EP000002334687B1
Searchable text: EP000002334687B1
Original document: WO002010023594
Searchable text: WO002010023594
43Date of first publicationEVTMar 4, 2010
Date of the first transfer into DPMAregisterEREGTAug 5, 2011
Date of the (most recent) update in DPMAregisterREGTJul 24, 2024
(Show all update days)(Hide all update days)
  • Jul 24, 2024
    • St.36: changed (technical change)
  • Jul 13, 2024; Jan 2, 2024; Dec 22, 2023; Jul 14, 2023; Jul 13, 2023; Jun 3, 2023; Jun 28, 2022; Jul 21, 2021; Jul 16, 2020; Aug 21, 2019; Aug 3, 2019; Jul 28, 2018; Sep 2, 2017; Sep 16, 2016; Sep 18, 2015; Sep 18, 2014; Sep 9, 2014; Sep 20, 2013; Sep 10, 2013; Jan 31, 2013; Sep 5, 2012; Apr 20, 2012; Apr 12, 2012; Mar 8, 2012; Jan 17, 2012; Jan 5, 2012
    • Historical data not available for this/these date(s)
  • Aug 5, 2011
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Mar 4, 2010  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Jun 22, 2011  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Aug 4, 2011 Aug 4, 2011 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 4, 2012  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Mar 8, 2012 Mar 8, 2012 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 5, 2012 Jan 31, 2013 Details anzeigen
7 New applicant/owner details New applicant/owner details Jun 2, 2023 Jul 13, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTMar 4, 2010
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJun 22, 2011
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTAug 4, 2011
Issue numberHN31
YearPJ2011
Publication dateVTAug 4, 2011
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 4, 2012
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMar 8, 2012
Issue numberHN10
YearPJ2012
Publication dateVTMar 8, 2012
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 5, 2012
Issue numberHN5
YearPJ2013
Publication dateVTJan 31, 2013
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 2, 2023
Issue numberHN28
YearPJ2023
Publication dateVTJul 13, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHPfizer Inc. (n.d.Ges.d.Staates Delaware), New York, NY, US
71/73Previous applicant/ownerINHFPfizer Inc., 10017 New York, N.Y., US
Date of update of the procedureREGTJul 13, 2023